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Effects of Statin Use on Endovascular Repair of Thoracic Aortic Aneurysm and Dissection
Objective: Mortality benefits of statin use in open and endovascular abdominal aortic aneurysm repair have been well documented. In this study, we sought to examine the effects of statin use on the outcomes of thoracic endovascular aortic repair (TEVAR).
Methods: The Vascular Quality Initiative data set was retrospectively queried to identify all patients who underwent TEVAR from 2010 to 2017. Univariate (c 2 test, t-test) and multivariate (logistic regression) methods were employed to evaluate the effects of statin use on postoperative outcomes after TEVAR.
Results: A total of 9147 patients underwent TEVAR, of whom 55% were taking statins. Patients taking statins were older (mean age [standard deviation], 71.4 [10.1] years vs 62.2 [17.0] years) and were more likely to be male (66% vs 63%) and white (79% vs 69%; all P < .001). The comorbidities were also significantly higher among statin users (Table I) . Statin users were more likely to be asymptomatic at presentation (67.4% vs 41.7%) and to undergo elective TEVAR (79.9% vs 55.7%), whereas nonstatin users were more likely to be symptomatic (49% vs 29%), to present with ruptured aneurysm (10% vs 4%), and to undergo urgent (24% vs 13%) and emergent (20% vs 7%) repair (all P < .001). Aortic dissection (32% vs 18%) was higher in nonstatin users, whereas aneurysm (66.9% vs 41.3%) was higher among statin users (P < .001). Conclusions: Using a large national vascular-specific database, we report differences in presentation, pathologic changes, and outcomes in statin vs nonstatin users undergoing TEVAR. Statins significantly reduce postoperative mortality and cardiac and renal complications after TEVAR for aortic dissection. However, no difference in outcomes was seen between the two groups after TEVAR for aortic aneurysm. This study suggests adding statin for all patients presenting with thoracic aortic dissection.
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Gut Bacteria Influence the Growth of Abdominal Aortic Aneurysms in Mice
Ian Stines, Trissa Babrowski. University of Chicago, Chicago, Ill
Objective: The goal of this study was to determine whether highly collagenolytic bacteria introduced to the gut microbiome induce abdominal aortic aneurysm in mice.
Methods: C57BL/6 mice received a prolonged 4-day course of preoperative antibiotics (oral clindamycin and subcutaneous cefoxitin) and received preoperative and postoperative enemas containing either 10% glycerol solution (control) or a freshly prepared bacterial suspension with a highly collagenolytic strain of Serratia marcescens (S2). All mice underwent laparotomy, aortic crush injury with forceps, and application of either 0.9% sodium chloride (control) or 10% calcium chloride to the periadventitial aortic space. Aortic diameter was measured on initial exposure and on sacrifice on postoperative day 21. Groups were compared using a series of Student t-tests.
Results: On postoperative day 21, the difference in aortic diameter for mice treated with periadventitial sodium chloride and glycerol enema was minimal (control 1 [n ¼ 6], 0.03 6 0.30 mm). In mice treated with periadventitial calcium chloride and glycerol enema, fusiform aneurysm was reliably produced compared with control 1 (control 2 [n ¼ 6], 0.53 6 0.30 mm; P .05). In mice treated with periadventitial sodium chloride and S2 enema, fusiform aneurysm was reliably produced with a significant difference in diameter compared with control 1 (n ¼ 8; 0.63 6 0.30 mm; P ¼ .05). In mice treated with periadventitial calcium chloride and S2 enema, fusiform aneurysm was reliably produced with a significant difference in diameter compared with control 1 (n ¼ 8; 0.59 6 0.30 mm; P ¼ .05). There was no significant difference between the two treatment groups.
Conclusions: The introduction of highly collagenolytic S. marcescens to the gut microbiome of mice in addition to aortic crush injury reliably produces fusiform aortic aneurysm in this model. Aortic aneurysm was reliably produced without chemical injury. Further investigation is required to elucidate the mechanism of aneurysm formation. Objective: The octopus endovascular strategy involves placement of a bifurcated graft in the thoracic segment of a thoracoabdominal aneurysm (TAAA) to facilitate deployment of multiple parallel covered stents for visceral perfusion. We reviewed our early outcomes of the octopus TAAA repair strategy.
Methods: All patients treated with an octopus approach from 2014 to 2017 were included. Our standardized approach included a Gore bifurcated main body component (W. L. Gore & Associates, Flagstaff, Ariz) with or without proximal thoracic extensions and multiple covered selfexpanding stents inserted from an axillary conduit in parallel fashion through the limbs for perfusion to up to four visceral branches.
Results: We treated 21 patients (48% female; age, 72.9 years) during 4 years. Mean TAAA diameter was 6.7 cm, with 14% of cases dissection related and 86% degenerative TAAAs; 14% were symptomatic, of which two were ruptures. All patients had been turned down for open repair. TAAA extent was 9% type II, 62% type III, and 29% type IV. A mean of 3.04 branches were perfused by the construct, with the superior mesenteric artery (90%) perfused through its own limb and both renal arteries (left, 90%; right, 85.7%) perfused in parallel fashion along with the distal extension though one of the limbs. The celiac was preserved in 33.3% of cases. Mean operative time was 8 hours, fluoroscopy time was 164 minutes, contrast material volume was 182 mL, and blood loss was 807 mL. The thoracic and juxtavisceral portions were staged in 24% of cases; 90% of cases were able to be completed with exclusion of the TAAA and all planned visceral branches cannulated. Perioperative complications included paraplegia (19%), acute kidney injury (24%), prolonged ventilation (19%), myocardial infarction (4.9%), and ischemic bowel (4.8%). On immediate postoperative imaging, the gutter endoleak rate was 19.1%, although 100% of these resolved by 6-month imaging. At latest followup, type I endoleak rate was 9.5%, and all were resolved with secondary intervention. Other secondary interventions included restenting of a right renal artery branch, angioplasty of an iliac limb kink, and coiling of a type II endoleak. Primary patency of visceral branches was 93.8% at latest follow-up (celiac, 100%; superior mesenteric artery, 94.7%; right renal, 88.9%; left renal, 94.8%). In-hospital all-cause mortality rate was 14.2%. The 30-day survival was 90.5%; 6-month survival, 88.3%; and 1-year survival, 71.4%.
Conclusions: The octopus procedure is a high-risk option for urgent and emergent endovascular TAAA repair with off-the-shelf devices in patients who are not candidates for open repair. 
